Neuroendocrine cells in prostate tumors are characterized by TP53 and Rb1 mutations, expression of neuroendocrine differentiation markers such as synaptophysin (SYP), neuron-specific enolase (NSE), neural cell adhesion molecule 1 (CD56), and absence of AR16,17. The gene discussed is NCAM1; the disease is prostate neoplasm.